Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer.

CONCLUSION: Continuous low dosage administration of olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer. PMID: 30740957 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30740957?dopt=Abstract

Source: Journal of Gynecologic Oncology - February 12, 2019 Category: OBGYN Tags: J Gynecol Oncol Source Type: research